Argenx Se (ARGX) Assets (2015 - 2026)
Argenx Se (ARGX) posted quarterly Assets of $10.0 billion for Q2 2026, up 39.81% year-on-year from $7.2 billion in Q2 2025, and up 15.54% on a QoQ basis from $8.7 billion in Q4 2025.
Argenx Se (ARGX) Assets (2015 - 2026) Analysis & Trends
Argenx Se (ARGX) has reported Assets for 12 consecutive years, with $10.0 billion the latest figure, recorded in Q2 2026.
- Quarterly Assets rose 39.81% year-over-year to $10.0 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $10.0 billion (up 39.81% YoY) and the FY2025 annual result came in at $8.7 billion, up 39.99% from the prior year.
- Assets improved to $10.0 billion in Q2 2026 per ARGX's latest filing, from $8.7 billion in the prior quarter.
- Over the last five years, Assets for ARGX reached as high as $10.0 billion in Q2 2026 and fell as low as $3.1 billion in Q4 2022.
- A 5-year average of $5.7 billion and a median of $4.8 billion in 2024 frame the typical range for Assets.
- Annual changes were most pronounced in 2023 — Assets slipped 1.71% — and 2024, when it soared 50.18%.
- Year by year, Assets stood at $3.1 billion in 2022, then surged by 44.93% to $4.5 billion in 2023, then soared by 36.55% to $6.2 billion in 2024, then surged by 39.99% to $8.7 billion in 2025, then climbed by 15.54% to $10.0 billion in 2026.
- According to Business Quant data, Assets over the past three periods registered $10.0 billion, $8.7 billion, and $7.2 billion for Q2 2026, Q4 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 311.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 78.88 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.55 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 39.68 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.48 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.87 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 811.27 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 10.03 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.25 Bn |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | 5.13 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.03 Bn |
| Dec 31, 2025 | 8.68 Bn |
| Jun 30, 2025 | 7.18 Bn |
| Dec 31, 2024 | 6.20 Bn |
| Jun 30, 2024 | 4.80 Bn |
| Dec 31, 2023 | 4.54 Bn |
| Jun 30, 2023 | 3.19 Bn |
| Dec 31, 2022 | 3.13 Bn |
| Jun 30, 2022 | 3.25 Bn |
| Dec 31, 2021 | 2.85 Bn |
| Jun 30, 2021 | 3.21 Bn |
| Dec 31, 2020 | 2.11 Bn |
| Jun 30, 2020 | 2.30 Bn |
| Dec 31, 2019 | 1.63 Bn |
| Jun 30, 2019 | 1.15 Bn |
| Dec 31, 2018 | 658.26 Mn |
| Jun 30, 2018 | 519.58 Mn |
| Dec 31, 2017 | 535.30 Mn |
| Jun 30, 2017 | 267.70 Mn |
| Dec 31, 2016 | 152.65 Mn |